Tags |
|
|
Links |
|
|
Digg It - List Building Techniques Part III
The exit pop-up should provide them with a final chance to sign up for you
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
r special free offer. You will at least have done all that you could have
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
done to get the address before your visitor left the site, probably forev
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
er.
When you are adding email addresses to your list, you must first info
When you are adding email addresses to your list, you must first info
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
rm the prospects that you will be emailing them. In that way they cannot
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ccuse you of spamming, and you should use a double opt-in system. After c
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ompleting the form, your autoresponder should send a confirmation email to
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
their Inbox, asking them to click on a link to confirm the registration.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
This is used as a safeguard, because people have bad memories and sometim
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
es forget filling in your form. They will rarely forget, however, both fi
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ling in the form and clicking on the confirmation. If they do, you are st
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ill safe from accusations of spamming since you have the evidence that the
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
y agreed twice to receive the information.
Doing this will enable you to
Doing this will enable you to
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
collect email addresses every time someone has reason to contact you, or e
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ven makes a purchase from you. You can add them to your list on condition
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
hat you have informed them beforehand, and operate a double opt-in system.
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
These are the most commonly used list-building techniques, but you shoul
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
d use any method you can to collect a first name and email address, as lon
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
g as people understand that you will be emailing them with information and
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
product offers. Do that and you will find it easier to make money online
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/71226/diggit-List-Building-Techniques-Part-III.html">List Building Techniques Part III</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/71226/diggit-List-Building-Techniques-Part-III.html]List Building Techniques Part III[/url]
Related Articles:
Subject Lines To Avoid- Spam-Alikes
Bookmark it:
|